Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Poseida Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 64 | 2 | 56 | −6 |
| Shares | 24.2M | 37.9K | 22.5M | −1.64M (−6.8%) |
| Value | $108.4M | $170.0K | $58.1M | −$50.1M (−46.3%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Poseida Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 545,700 | $1.41M | 0.06% |
| Ergoteles LLC | 136,320 | $352.0K | 0.01% |
| Barr E S & Co | 76,398 | $197.0K | 0.02% |
| RBF Capital, LLC | 70,171 | $181.0K | 0.01% |
| HighTower Advisors, LLC | 34,000 | $88.0K | 0.00% |
| Qube Research & Technologies Ltd | 27,387 | $71.0K | 0.00% |
| State of Tennessee, Treasury Department | 18,705 | $48.0K | 0.00% |
| Acadian Asset Management LLC | 12,099 | $31.0K | 0.00% |
| LMR Partners LLP | 10,258 | $26.0K | 0.00% |
| Advisor Group Holdings, Inc. | 251 | $1.00K | 0.00% |
| Credit Suisse AG | 15 | $0 | 0.00% |
| Ellevest, Inc. | 7 | $0 | 0.00% |
Sold out (18)
Institutions that held Poseida Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Rock Springs Capital Management LP | 289,754 | $1.30M |
| Nuveen Asset Management, LLC | 98,962 | $463.0K |
| Rhumbline Advisers | 34,064 | $153.0K |
| Regent Investment Management LLC | 20,922 | $94.0K |
| Martingale Asset Management L P | 16,116 | $73.0K |
| Deutsche Bank AG | 15,619 | $70.0K |
| Manufacturers Life Insurance Company, The | 14,614 | $65.5K |
| American International Group, Inc. | 14,279 | $64.0K |
| Nisa Investment Advisors, LLC | 13,000 | $58.0K |
| California State Teachers Retirement System | 12,383 | $55.0K |
| ProShare Advisors LLC | 11,861 | $53.0K |
| Voya Investment Management LLC | 11,437 | $51.0K |
| Prelude Capital Management, LLC | 11,250 | $50.0K |
| Amalgamated Bank | 3,462 | $16.0K |
| Ameritas Investment Partners, Inc. | 2,693 | $12.0K |
| Legal & General Group Plc | 2,310 | $10.0K |
| Toronto Dominion Bank | 3 | $0 |
| Simplex Trading, LLC | 120 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Poseida Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 34,470 | $154.0K |
| Amalgamated Financial Corp. | 3,462 | $16.0K |